Kenvue Inc. $KVUE Shares Bought by M&T Bank Corp

M&T Bank Corp raised its stake in Kenvue Inc. (NYSE:KVUE) by 3,054.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,334,186 shares of the company’s stock after acquiring an additional 2,260,201 shares during the period. M&T Bank Corp’s holdings in Kenvue were worth $40,265,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Cornerstone Planning Group LLC boosted its stake in Kenvue by 705.2% in the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after acquiring an additional 1,361 shares in the last quarter. NBT Bank N A NY raised its holdings in shares of Kenvue by 180.3% in the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after buying an additional 1,006 shares during the last quarter. Salomon & Ludwin LLC purchased a new stake in shares of Kenvue in the third quarter valued at about $25,000. Golden State Wealth Management LLC raised its holdings in shares of Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after buying an additional 1,190 shares during the last quarter. Finally, Trust Co. of Vermont raised its holdings in shares of Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after buying an additional 804 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Kenvue Trading Down 0.0%

NYSE KVUE opened at $17.30 on Thursday. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $33.21 billion, a P/E ratio of 22.47, a P/E/G ratio of 3.93 and a beta of 0.61. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The firm has a 50-day moving average price of $17.87 and a 200 day moving average price of $17.13.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. The firm had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The firm’s revenue was up 3.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.26 earnings per share. Equities research analysts expect that Kenvue Inc. will post 1.1 EPS for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a $0.2075 dividend. The ex-dividend date was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. Kenvue’s dividend payout ratio (DPR) is presently 107.79%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on KVUE shares. Jefferies Financial Group cut shares of Kenvue from a “buy” rating to a “hold” rating and reduced their target price for the company from $23.00 to $18.00 in a report on Friday, January 30th. Citigroup reduced their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Barclays reduced their target price on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday, April 14th. Argus raised shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Finally, Canaccord Genuity Group upped their target price on shares of Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a report on Wednesday, February 18th. Three analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to MarketBeat, Kenvue has an average rating of “Hold” and an average price target of $19.33.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.